ENTITY
Hyphens Pharma International

Hyphens Pharma International (HYP SP)

30
Analysis
Health CareSingapore
Hyphens Pharma International Limited is Singapore’s leading specialty pharmaceutical and consumer healthcare group. It develops and owns several dermatological products and supplements, such as Ceradan, TDF and Ocean Health. The Group also markets and sells specialty pharmaceutical products through exclusive agreements, as well as operates an online B2B platform for healthcare professionals. Please visit us at https://www.hyphensgroup.com for more information.
more
bullishHuationg Global
08 Apr 2024 10:00Exchange-sponsored

Huationg Global CEO increases interest to 7.75%

Huationg Global CEO increases interest to 7.75% Olam Group bought back a total of three million shares at S$1.13 apiece over the four sessions. Ng...

Share
13 May 2022 08:00Exchange-sponsored

(Non-SGX Report) Hyphens Pharma International - Building up the HYPe

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
02 Mar 2022 08:00Exchange-sponsored

(Non-SGX Report) Hyphens Pharma International - Quality Earnings to Come in FY22F

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
06 Jan 2022 08:00Exchange-sponsored

(Non-SGX Report) Hyphens Pharma International Ltd - On the Lookout for Growth

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
24 Aug 2021 08:00Exchange-sponsored

(Non-SGX Report) Hyphens Pharma International Limited: Strongest 1H Recorded

Non- SGX Report: These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external...

Share
x